Explore the latest developments concerning Trump should keep.
EU drug landscape feeling Trumpian tumult
AS US pricing policies disrupt the world's pharmaceutical sector, Europe is at a pivotal moment of ensuring future access to new drugs, the head of the European Medicines Agency (EMA), Emer Cooke (pictured) told attendees at last week's Reuters Pharma Europe 2026 event.
President Donald Trump's most-favoured-nation drug pricing policy introduced last May was intended to cut the cost of medicines for people in the US, but has instead led pharma companies to push for higher prices elsewhere or delay launches, Cooke explained.
As a result, the number of drug launches in Europe has fallen by more than a third, potentially hindering patient access to the latest innovative medicines.
VEVOR 8 Pack Buffet Chafing Dishes 5.93L Gastronorm Pans Steam Table Pans Tray with Lid 6-Inch Deep Catering Food Pan
The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.
For more detailed information, explore updates concerning Trump should keep.
0 Comments